Name tag

Sam North

Education

Royal Australian Navy - Electronic and Communications Advanced Diploma (TAFE).

Written For

Releaf, Fast Buds, MSNL, Paradise Seeds, Cookies Seeds, Premium Cultivars

With a background in cannabis journalism - writing for Fast Buds, Paradise Seeds, Cookies Seeds Co., MSNL, and now Releaf, Sam is an experienced cannabis expert who understands how to communicate complex ideas clearly. Collaborating with clients throughout the global cannabis industry, he has cemented himself as a leading voice within both the recreational and medicinal sectors. Whether it’s researching, writing, editing, or consulting, Sam has a commitment to accuracy and quality that clients and audiences connect to. Based between Asia, Australia, and Europe, Sam is passionate about educating and enlightening people on all aspects of cannabis. By translating scientific data into easily understandable language, he strives to bridge the gap between the medical and recreational cannabis communities. Sam believes that with the proper education, correct understanding, and honest information, everyone can benefit from the natural healing power of cannabis.

Releaf articles

Why fewer than 1% of UK doctors are trained in medical cannabis and how Releaf is working to change it

Reports suggest that fewer than 1% of eligible UK specialists are trained to prescribe medical cannabis. This gap leaves many patients without informed support. This outline explains why the gap exists and how Releaf’s clinicians follow a structured, evidence-based training pathway that leads the industry. It also highlights Releaf’s wider educational work, including police workshops that improve understanding of legal patient access.

Can medical cannabis and CBD support people with sleep apnoea (updated)?

Sleep apnoea can affect concentration, energy levels and overall wellbeing. This updated guide explains how medical cannabis and CBD may support people living with sleep apnoea, what current research shows and how treatment works in the UK. It also covers risks, product types and the role of established treatments such as CPAP.

Decoding Cannabis: what a recent scoping review reveals about cannabis for rheumatoid arthritis

A recent scoping review has dug into how cannabinoids interact with inflammation, joint tissue, and pain signalling in rheumatoid arthritis. This article breaks down what the researchers found, how THC and CBD influence key inflammatory pathways, and what these insights may mean for people living with arthritis in the UK. We also look at how this evidence compares with current patient experiences.